623
Views
4
CrossRef citations to date
0
Altmetric
Laboratory Study

Biological Effects of Lentivirus-Mediated shRNA Targeting Collagen Type I on the Mesangial Cells of Rats

, , &
Pages 334-340 | Received 26 Jul 2010, Accepted 27 Jan 2011, Published online: 14 Mar 2011

REFERENCES

  • Zhou CH, Gao CF, Mei CL. Biological function and transcriptional regulation of collagen type I. Chin J Nephrol Dial Transplant. 2001;10(5):468–472.
  • Ortega-Velazquez R, Gonzalez-Rubio M. Collagen I upregulates extracellular matrix gene expression and secretion of TGF-β1 by cultured human mesangial cells. Am J Physiol Cell Physiol. 2004;1:C1335–C1343.
  • Lin SL, Kisseleva T, Brenner DA, Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol. 2008;173(6):1617–1627.
  • Shrey K, Suchit A, Nishant M, RNA interference: Emerging diagnostics and therapeutics tool. Biochem Biophys Res Commun. 2009;386(2):273–277.
  • Krishnan P, Gireesh-Babu P, Rajendran KV, RNA interference-based therapeutics for shrimp viral diseases. Dis Aquat Organ. 2009;86(3):263–272.
  • López-Fraga M, Martínez T, Jiménez A. RNA interference technologies and therapeutics: From basic research to products. BioDrugs. 2009;23(5):305–332.
  • Vázquez-Vega S, Contreras-Paredes A, Lizano-Soberón M, RNA interference (RNAi) and its therapeutic potential in cancer. Rev Invest Clin. 2010;62(1):81–90.
  • Tiemann K, Rossi JJ. RNAi-based therapeutics-current status, challenges and prospects. EMBO Mol Med. 2009;1(3):142–151.
  • Shrey K, Suchit A, Nishant M, RNA interference: Emerging diagnostics and therapeutics tool. Biochem Biophys Res Commun. 2009;386:273–277.
  • Sumimoto H, Kawakami Y. Lentiviral vector-mediated RNAi and its use for cancer research. Future Oncol. 2007;3:655–664.
  • Lesch HP, Pikkarainen JT, Kaikkonen MU, Avidin fusion protein-expressing lentiviral vector for targeted drug delivery. Hum Gene Ther. 2009;20(8):871–882.
  • Flotte TR. Gene therapy: The first two decades and the current state-of-the-art. J Cell Physiol. 2007;213(2):301–305.
  • Yang M, Mattes J. Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs. Pharmacol Ther. 2008;117:94–104.
  • Lech P, Scmia NV. Retrovirus vectors. Contrib Nephrol. 2008;159(1):30–46.
  • Singer O, Verma IM. Applications of lentiviral vectors for shRNA delivery and transgenesis. Curr Gene Ther. 2008;8(6):483–488.
  • Morin A, Gallou-Kabani C, Mathieu JR, Systemic delivery and quantification of unformulated interfering RNAs in vivo. Curr Top Med Chem. 2009;9(12):1117–1129.
  • Dissen GA, Lomniczi A, Neff TL, In vivo manipulation of gene expression in non-human primates using lentiviral vectors as delivery vehicles. Methods. 2009;49(1):70–77.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.